COUNCODOS · Real Estate · Real Estate - Development
Composite scorecard: 19/100 — Quality 33 · Valuation 8 · Momentum 5
| Share price | ₹6.60 |
| Market cap | ₹45 Cr |
| P/E ratio | 73.2 |
| P/B ratio | 2.0 |
| ROE | 7.6% |
| ROCE | 3.4% |
| Book value | ₹2.87 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹17 Cr | ₹1 Cr | 4.9% |
| 2025 | ₹17 Cr | ₹1 Cr | 4.8% |
| 2024 | ₹25 Cr | ₹2 Cr | 5.9% |
| 2023 | ₹21 Cr | ₹1 Cr | 5.7% |
| 2022 | — | — | — |
Country Condo's Limited engages in the real estate business in India. The company procures land banks; develops residential layouts; constructs compound walls; and sells plots. It also provides contract research services. The company was formerly known as Neocure Therapeutics Ltd. and changed its name to Country Condo's Limited in December 2006. Country Condo's Limited was incorporated in 1987 and is headquartered in Hyderabad, India.